Sight Sciences, Inc.
Clinical trials sponsored by Sight Sciences, Inc., explained in plain language.
-
Second treatment tested to make dry eye relief last
Disease control CompletedThis study tested whether giving a second TearCare treatment to people with dry eye syndrome could extend the benefits they got from their first treatment. It followed 12 adults for an extra 6 months to check if the second treatment was safe and continued to help with dry eye sym…
Phase: NA • Sponsor: Sight Sciences, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New device tested to combat dry, irritated eyes
Symptom relief CompletedThis study tested a medical device called the TearCare System to see if it is safe and effective at relieving the signs and symptoms of dry eye disease. It was compared directly to another approved treatment called LipiFlow. The trial involved 235 adults with dry eye caused by bl…
Phase: NA • Sponsor: Sight Sciences, Inc. • Aim: Symptom relief
Last updated Apr 03, 2026 14:42 UTC
-
15-Minute In-Office treatment tested for dry eye relief
Symptom relief CompletedThis study tested a single, 15-minute in-office treatment called the TearCare System to see if it could safely improve dry eye symptoms. Twenty-nine adults with moderate to severe dry eye received the treatment and were followed for one month. The goal was to see if the procedure…
Phase: NA • Sponsor: Sight Sciences, Inc. • Aim: Symptom relief
Last updated Mar 30, 2026 14:35 UTC
-
Device challenges popular eye drops in battle against dry eye
Symptom relief CompletedThis study tested whether the TearCare system, a device that applies controlled heat to the eyelids, works as well as or better than Restasis eye drops for treating dry eye disease. It involved 345 adults with moderate to severe dry eye symptoms. Researchers compared how much eac…
Phase: NA • Sponsor: Sight Sciences, Inc. • Aim: Symptom relief
Last updated Mar 30, 2026 14:34 UTC
-
Quick clinic treatment tested for dry eye relief
Symptom relief CompletedThis small, completed pilot study compared a single 12-minute in-office eyelid treatment (TearCare) to 4 weeks of daily 5-minute warm compress therapy for adults with dry eye disease. The goal was to see if the brief TearCare procedure was a safe and effective alternative to the …
Phase: NA • Sponsor: Sight Sciences, Inc. • Aim: Symptom relief
Last updated Mar 19, 2026 14:55 UTC